1) Cyclophosphamide monochemotherapy procures complete remission, with only slight morbidity, and remains effective against relapses.

2) Cyclophosphamide important color production paths ( high fidelity ).

3) Objective: To observe the effect of cyclophosphamide and recombinant human granulocyte colony-stimulating factor(rhG-CSF, Filgrastim ) on autologous peripheral blood stem cells mobilization.

4) Treatment with immunosuppressants such as rituximab, azathioprine and cyclophosphamide resulted in a marked reduction in antibody levels and relapse rates.

5) Linev with cyclophosphamide. The composition , consisting of a vertical line with in a solemn feeling.

6) Conclusion Cyclophosphamide is effective in the treatment of severe Still's disease in children.

7) Palliative therapy involving cyclophosphamide, vincristine and dacarbazine have been conducted for malignant pheochromocytoma. 131I-MIBG and 123I-MIBG may also be used.

8) Conclusion Cyclophosphamide has impact on thymocyte subpopulation, hydrocortisone has impact on peripheral blood and spleen T lymphocytes.

9) The pretreatment regimen was Cytarabine, Etoposide,(http:///cyclophosphamide.html) Cyclophosphamide and total body irradiation.

10) Cyclophosphamide an alkylating agent designed to improve the selectivity of cancer drugs approved by FDA.

11) Lumpectomy followed by 6 courses of CMF ( cyclophosphamide, methotrexate, fluorouracil ).

12) Conclusion: Cyclophosphamide may causes immunosuppression through the induction of apoptosis of thymocyte.

13) Complete remission was obtained in six patients including four treated with cyclophosphamide, with a follow up ranging from 1.5-7 years.

14) These include some drugs commonly used as cancer chemotherapies such as cyclophosphamide, methotrexate and mitoxantrone.

15) Results and Conclusion : The results suggested that the variation of cell cycle and the occurrence of apoptosis might be involved in cyclophosphamide - induced teratogenicity .

16) OBJECTIVE To study the protective effect of tetramethyl pyrazine (TMP) on cyclophosphamide injured mice.

17) METHODS: The blood deficient mice model was induced by injection of phenylhydrazine and cyclophosphamide.

18) She responded well to pulse therapy with methylprednisolone and cyclophosphamide and the administration of warfarin.

19) Objective : To study the counteraction of melatonin ( MT ) on the immunodepression induced by cyclophosphamide ( CY ) and dexamethasone ( DEX ).

20) Her breast and pulmonary lesions were successfully treated with high - dose corticosteroid and cyclophosphamide.

21) Corticosteroids (pulsed methylprednisolone) are usually used for the treatment of NBD, followed by cyclophosphamide (pulsed) and azathioprine.

22) METHOD:To observe the effect of S-8300 on the formulation of serum haemolysin[], PFC and the content of IL-2 in serum of the immunosuppression mice caused by cyclophosphamide(Cy).

23) In this paper, we have studied the effect of medicinal vesiculation on the hematopoietic function and its mechanism in mice treated by Cyclophosphamide.

24) Objective To discuss the adverse reactions and the nursing features of the patient children with advanced neuroblastoma treated by cyclophosphamide, daunorubicin and vincristine (CDV).

25) FGL can improve the lower humoral immunity of mice caused by Cyclophosphamide, improve the ability of reticuloendothelial system of body to phagocytiae foreign body.

26) To use high - dose steroids ( dexamethasone ) and cyclophosphamide to treat 9 cases of severe pemphigus.

27) Objective:To investigate for nursing measures about double medication stoss therapy of lupus nephritis by me thy prednisolone and cyclophosphamide.

28) Conclusion Xiaoliuwan pill can inhibit growth of S 180 tumor cell line and has synergism with cyclophosphamide.

29) OBJECTIVE To observe the efficacy and toxicity of vindesine(VDS), pirarubicin(THP), cyclophosphamide(CTX) and dexamethasone(DXM) combination therapy for non-Hodgkin s lymphoma.

30) At the same time, give them metronomic chemotherapy by taking low-dose of compound cyclophosphamide and compound tegafur.

31) Objective To study the suppressive effect of cyclophosphamide (CTX) toxicity by carnosine in mice.

32) Methods: The tumor - bearing mice model was established, then given to Guizhi Fuling Bolus and cyclophosphamide, ig.

33) Pretreatment of patients consisted of a combination of antithymocyte globulin , cyclophosphamide, and low - dose total body irradiation.